Univariate analysis | Multivariate analysis | |||||
HR | 95% CI | P value | HR | 95% CI | P value | |
EXT1 | 2.895 | 1.035 to 8.101 | 0.043 | 5.647 | 1.323 to 12.048 | 0.019 |
C3 | 0.990 | 0.975 to 1.005 | 0.191 | 0.994 | 0.970 to 1.019 | 0.640 |
MAP | 1.034 | 0.995 to 1.073 | 0.087 | 1.037 | 0.988 to 1.088 | 0.143 |
Anti-SSA | 3.074 | 1.003 to 9.417 | 0.051 | 2.525 | 0.623 to 10.227 | 0.149 |
Anti-SSB | 3.344 | 1.502 to 7.447 | 0.087 | 1.577 | 0.517 to 4.810 | 0.423 |
WBC | 0.817 | 0.655 to 1.019 | 0.073 | 0.853 | 0.703 to 1.035 | 0.108 |
AI | 1.288 | 0.890 to 1.865 | 0.179 | 0.500 | 0.252 to 0.992 | 0.055 |
P<0.05 is considered significant. Data with significant differences are highlighted in bold.
AI, activity index; anti-SSA, anti-Sjögren syndrome A antibody; anti-SSB, anti-Sjögren syndrome B antibody; EXT1, exostosin 1; MAP, mean arterial pressure; WBC, white blood cell.